Engineered Oral Patch Delivers Plant-Derived Cyclic Peptide for Type 2 Diabetes | Research

The takeaway

An engineered micropatch enables oral delivery of heterophyllin B, a cyclic peptide from Pseudostellaria Radix, that treats type 2 diabetes by modulating insulin signaling pathways.

Oral cyclic peptide delivery
Micropatch solves bioavailability challenge for plant-derived diabetes peptide

What the researchers found

Engineered micropatch enables oral delivery of heterophyllin B, a cyclic plant peptide that alleviates T2DM by modulating hepatic IRS2/PI3K-Akt/FoxO1 signaling and restoring bile acid metabolism.

Why it matters

Traditional medicine contains many potential diabetes drugs that can't be taken orally. Engineering delivery systems that work for cyclic peptides could unlock a whole class of natural therapeutics.

How the study worked

Preclinical study with mechanistic pathway analysis, metabolomics, and micropatch oral delivery system engineering for heterophyllin B.

What this study cannot tell us

Preclinical study; micropatch technology needs scalability assessment; long-term safety in humans unknown; regulatory pathway for traditional medicine-derived peptides is complex.

How to read the evidence

Preclinical study with pathway validation and delivery engineering — proof of concept for oral peptide delivery.

When this study was published

Published in 2026, advancing oral peptide delivery technology for natural product therapeutics.

The bigger picture

This bridges traditional Chinese medicine and modern drug delivery engineering — validating an ancient remedy's mechanism of action and solving its bioavailability problem with nanotechnology.

Questions still open

Could the micropatch platform be used for other cyclic peptide drugs with poor oral bioavailability?
How does heterophyllin B compare to metformin or GLP-1 drugs for T2DM efficacy?

Common questions

What is heterophyllin B?

It's a cyclic peptide found in Pseudostellaria Radix, a plant used in traditional Chinese medicine. Research shows it can improve diabetes by helping the liver respond better to insulin and restoring metabolic balance.

Why does it need a special delivery system?

Like most peptide drugs, heterophyllin B gets destroyed by stomach acid and digestive enzymes. The engineered micropatch protects it through the digestive system and helps it get absorbed into the bloodstream intact.

Read the original research

An engineered micropatch for oral delivery of heterophyllin B in type 2 diabetes treatment.

Journal of controlled release : official journal of the Controlled Release Society, 114782

View on PubMed ↗Publisher’s paper ↗

Citation

Chen, Yi; Huang, Yuanxing; Huang, Cheneryu; Zhang, Shu; Fan, Mengyu; Yuan, Xu; Huang, Cao; Zhang, Man; Peng, Jianqing; Sun, Runbin; Zhang, Shuai; Chen, Wenzhang; Gong, Zipeng. (2026). An engineered micropatch for oral delivery of heterophyllin B in type 2 diabetes treatment.. Journal of controlled release : official journal of the Controlled Release Society, 114782. https://doi.org/10.1016/j.jconrel.2026.114782